SPATOLA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 550
EU - Europa 123
AS - Asia 30
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 707
Nazione #
US - Stati Uniti d'America 549
IT - Italia 59
CN - Cina 23
BE - Belgio 17
DE - Germania 13
RO - Romania 10
GB - Regno Unito 8
IE - Irlanda 5
RU - Federazione Russa 4
IN - India 3
IR - Iran 2
SE - Svezia 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
HK - Hong Kong 1
KR - Corea 1
NO - Norvegia 1
Totale 707
Città #
Chandler 87
Fairfield 87
Woodbridge 53
Ann Arbor 48
Seattle 34
Ashburn 33
Wilmington 29
Houston 27
Cambridge 23
Des Moines 18
Brussels 17
Altamura 16
Medford 13
Palermo 11
Lawrence 10
Princeton 10
San Diego 10
San Paolo di Civitate 7
Bremen 6
Dublin 5
London 5
Boardman 3
Kumar 3
Milan 3
Nanchang 3
Nanjing 3
Shenyang 3
Venice 3
Cologne 2
Oakland 2
Zhengzhou 2
Bethesda 1
Bobingen 1
Central 1
Changsha 1
Chicago 1
Dearborn 1
Haikou 1
Jiaxing 1
Jinan 1
Leawood 1
Napoli 1
New Bedfont 1
Oslo 1
Ottawa 1
Phoenix 1
Redmond 1
Rome 1
Santiago 1
Seongnam 1
São Paulo 1
Taiyuan 1
Tianjin 1
Tulsa 1
Verona 1
Totale 600
Nome #
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? 153
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 124
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives 107
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives 103
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION 70
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population 56
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 52
Systemic therapies for hepatocellular carcinoma: The present and the future 38
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease 37
Biochemical biomarkers of NAFLD/NASH 34
Totale 774
Categoria #
all - tutte 2.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 3 2 6 7
2019/2020155 6 1 1 18 7 36 17 14 22 11 21 1
2020/2021187 6 14 20 27 12 5 19 10 15 23 23 13
2021/2022149 9 18 5 6 3 2 5 22 15 13 29 22
2022/2023232 24 54 1 32 19 45 15 12 16 1 5 8
2023/202433 5 17 11 0 0 0 0 0 0 0 0 0
Totale 774